by Ellie Lampton | Jan 31, 2025
New research published in JAMA Network Open led by Truveta Research and Ezekiel Emanuel, MD, PhD, Perelman School of Medicine at University of Pennsylvania BELLEVUE, Wash. – January 31, 2025 – Truveta’s groundbreaking study analyzing real-world use of GLP-1 receptor...
by Ellie Lampton | Jan 13, 2025
The Regeneron Genetics Center® will sequence up to ten million exomes, helping to accelerate drug discovery and transform patient care BELLEVUE, Wash. – January 13, 2025 – Today, leading US health systems, including Advocate Health, CommonSpirit Health, Henry Ford...
by Ellie Lampton | Nov 20, 2024
HITRUST r2 Certification demonstrates Truveta’s relentless commitment to the highest standards of security and privacy to protect regulatory-grade data. BELLEVUE, Wash. – November 20, 2024 – Truveta announced that its platform Truveta Studio and Truveta Data have...
by Ellie Lampton | Nov 14, 2024
Researchers with more than 100 organizations use regulatory-grade Truveta Data to enable their scientifically rigorous research BELLEVUE, Wash. – November 14, 2024 –Truveta announced today that Truveta Data, the most complete, timely, and clean electronic health...
by Ellie Lampton | Oct 28, 2024
Trained on the Truveta Language Model and Truveta Data, the most complete and representative EHR data, Tru enables researchers to accelerate their research in Truveta Studio using simple, natural language BELLEVUE, Wash. – October 29, 2024 – Today, Truveta announced...
